Zhao Fuzhen,Hu Lijun,Yu Jingping.Progress in the application of poly ADP-ribose polymerase inhibitors in tumor radiotherapy[J].Chinese Journal of Radiological Medicine and Protection,2021,41(10):796-800
Progress in the application of poly ADP-ribose polymerase inhibitors in tumor radiotherapy
Received:May 06, 2021  
DOI:10.3760/cma.j.issn.0254-5098.2021.10.013
KeyWords:PARP inhibitors  Radiation therapy  Malignant tumors
FundProject:江苏省"333工程"第二层次人才科研资助项目(BRA2019025)
Author NameAffiliationE-mail
Zhao Fuzhen Graduate School of Dalian Medical University, Dalian 116000, China  
Hu Lijun Department of Radiotherapy, Changzhou No. 2 People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China  
Yu Jingping Department of Radiotherapy, Changzhou No. 2 People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China yujingping700420@sina.com 
Hits: 2664
Download times: 1277
Abstract::
      The poly ADP-ribose polymerase (PARP) is a class of nuclear enzymes highly expressed in eukaryotic cells and plays a key role in DNA damage repair. In recent years, PARP inhibitors have shown great potential in tumor therapy, and several PARP inhibitors have been approved by the FDA for maintenance therapy of a variety of cancers. PARP inhibitors mainly inhibit PARP enzymes and PARP trapping, resulting in the persistence of DNA single strand breaks, which are converted to double strand breaks during DNA replication. Studies have shown that PARP inhibitors not only have a significant anti-tumor effect, but also have a synergistic effect with radiotherapy. This paper reviewed the potential theoretical basis of PARP inhibitor combined with radiotherapy, summarized the recent progress of preclinical and clinical research on PARP inhibitors in tumor radiotherapy, sorted out the urgent problems in this field, and looked into the application prospect of PARP inhibitors in anti-tumor therapy.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:12029835  On-line:0

v
Scan QR Code
&et=36358E19F9C507AE40294F9FC92ED085F2D28B05CD23EBC53A29F39FF1F2C8A1EA3BC50165337A13486A7D6F3FEA4247EF7EAECABEA9734119B0BF4ACB69688287CF6A1608F2E4B1DB8A80CC9BAB22D34696B4D0E04CD0364852C0C6D28FAB40&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9475FABC7A03F4AB&aid=11709EAE29D30158E6CAAE6A883EB37A&vid=&iid=F3090AE9B60B7ED1&sid=6920A1020E13BE87&eid=FE6645F2371CA43C&fileno=20211013&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9475FABC7A03F4AB"; var my_aid="11709EAE29D30158E6CAAE6A883EB37A";